Focus Point Holdings (0157) Fair Value & Analysis
Healthcare · MY · Market cap 326M MYR
Fair value as of: Jun 25, 2026
Analysis
Focus Point Holdings (0157) currently trades at 0.5150 MYR, while our model-based Fair Value estimate is 1.25 MYR — implying the stock looks roughly 142.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
About the company
Focus Point Holdings Berhad, an investment holding company, operates professional eye care centers in Malaysia. The company operates through two segments: Optical and Food and Beverages. It is also involved in the trading of eyewear and eye care products; and management of franchised professional eye care centers, and food and beverage outlets. In addition, the company provides medical eye care and laser eye surgery treatment services; vision care and eyewear services; food and beverages services; and retails optical related and other food products. Further, it offers screenings for eye related diseases, such as hypertensive retinopathy and diabetic retinopathy; and ophthalmology and optometric treatment services. The company operates its stores under the Focus Point, Focus Point Signature, Focus Point Concept Store, Focus Point Lifestyle, Focus Point SightSavers, Focus Point Outlet, Eyefont, Opulence, i-Focus, Whoosh Eyewear, Eyefont, Optometris Anggun, Komugi, and HAP&PI Frozen Yo…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Focus Point Holdings (0157) undervalued?
What is the fair value of 0157?
What is the quality score of 0157?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.